Literature DB >> 19229055

Deletion of five residues from the coiled coil of fibrinogen (Bbeta Asn167_Glu171del) associated with bleeding and hypodysfibrinogenemia.

Stephen O Brennan1, Ryan L Davis, Robin Lowen, Anna Ruskova.   

Abstract

Routine pre-surgical coagulation investigations led to the detection of a novel type of hypodysfibrinogenemia whose functional defect appears to result from an alteration in the spacing between the functional domains of the fibrinogen molecule. The detection, by reverse phase HPLC, of a minor isoform of Bbeta chain with a 554 Da decrease in mass led to the identification of a deletion of five amino acids (NVVNE) from the center of the coiled coil. The variant chain contributed only 10% of the total Bbeta material and the mutation (BbetaAsn167_Glu171del) was associated with both increased clotting times and low functional and physical fibrinogen concentrations in 3 family members. There was a significant history of pregnancy-associated bleeding and miscarriage within the first trimester. Mechanistically the 15-nucleotide deletion appears to arise from replication advancement during DNA synthesis caused by a flanking pentanucleotide repeat of AATGA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19229055      PMCID: PMC2663623          DOI: 10.3324/haematol.2008.001412

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  13 in total

1.  Crystal structure of native chicken fibrinogen at 2.7 A resolution.

Authors:  Z Yang; J M Kollman; L Pandi; R F Doolittle
Journal:  Biochemistry       Date:  2001-10-23       Impact factor: 3.162

Review 2.  Encoded errors: mutations and rearrangements mediated by misalignment at repetitive DNA sequences.

Authors:  Susan T Lovett
Journal:  Mol Microbiol       Date:  2004-06       Impact factor: 3.501

3.  The sialic acid content of fibrinogen decreases during pregnancy and increases in response to fibrate therapy.

Authors:  Ghassan J Maghzal; Stephen O Brennan; Peter M George
Journal:  Thromb Res       Date:  2005       Impact factor: 3.944

4.  A frame shift mutation in the fibrinogen A alpha chain gene in a kindred with renal amyloidosis.

Authors:  T Uemichi; J J Liepnieks; T Yamada; M A Gertz; N Bang; M D Benson
Journal:  Blood       Date:  1996-05-15       Impact factor: 22.113

5.  Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A alpha 20 Val --> Asp).

Authors:  S O Brennan; B Hammonds; P M George
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

6.  Hypofibrinogenemia in an individual with 2 coding (gamma82 A-->G and Bbeta235 P-->L) and 2 noncoding mutations.

Authors:  S O Brennan; A P Fellowes; J M Faed; P M George
Journal:  Blood       Date:  2000-03-01       Impact factor: 22.113

7.  A simple method for DNA purification from peripheral blood.

Authors:  T A Ciulla; R M Sklar; S L Hauser
Journal:  Anal Biochem       Date:  1988-11-01       Impact factor: 3.365

8.  Fibrinogen stabilizes placental-maternal attachment during embryonic development in the mouse.

Authors:  Takayuki Iwaki; Mayra J Sandoval-Cooper; Melissa Paiva; Takao Kobayashi; Victoria A Ploplis; Francis J Castellino
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

9.  Fibrinogen B beta polymorphisms do not directly contribute to an altered in vitro clot structure in humans.

Authors:  Ghassan J Maghzal; Stephen O Brennan; Peter M George
Journal:  Thromb Haemost       Date:  2003-12       Impact factor: 5.249

10.  Severe hypodysfibrinogenemia in compound heterozygotes of the fibrinogen AalphaIVS4 + 1G>T mutation and an AalphaGln328 truncation (fibrinogen Keokuk).

Authors:  Phil Lefebvre; Pauline T Velasco; Amy Dear; Karim C Lounes; Susan T Lord; Stephen O Brennan; David Green; Laszlo Lorand
Journal:  Blood       Date:  2003-11-13       Impact factor: 22.113

View more
  3 in total

1.  Congenital hypodysfibrinogenemia associated with a novel deletion of three residues (γAla289_Asp291del) in fibrinogen.

Authors:  Liqing Zhu; Misheng Zhao; Mingshan Wang; Zhefeng Lou; Xiaoli Chen; Liangliang Pan; Dandan Yu; Wenli Xia; Han Wang; Bin Zhou; Shenmeng Gao
Journal:  J Thromb Thrombolysis       Date:  2018-08       Impact factor: 2.300

2.  A novel fibrinogen mutation: FGA g. 3057 C > T (p. Arg104 > Cys) impairs fibrinogen secretion.

Authors:  R Marchi; M Linares; H Rojas; A Ruiz-Sáez; M Meyer; A Casini; S O Brennan
Journal:  BMC Hematol       Date:  2017-12-22

3.  A Novel Mutation in the Fibrinogen Bβ Chain (c.490G>A; End of Exon 3) Causes a Splicing Abnormality and Ultimately Leads to Congenital Hypofibrinogenemia.

Authors:  Chiaki Taira; Kazuyuki Matsuda; Shinpei Arai; Mitsutoshi Sugano; Takeshi Uehara; Nobuo Okumura
Journal:  Int J Mol Sci       Date:  2017-11-20       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.